Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers

Photodynamic therapy (PDT) is a treatment for cancer and for certain benign conditions that is based on the use of a photosensitizer and light to produce reactive oxygen species in cells. Many of the photosensitizers currently used in PDT localize in different cell compartments such as mitochondria,...

Full description

Saved in:
Bibliographic Details
Published inBiochemical pharmacology Vol. 66; no. 8; pp. 1651 - 1659
Main Authors Piette, Jacques, Volanti, Cédric, Vantieghem, Annelies, Matroule, Jean-Yves, Habraken, Yvette, Agostinis, Patrizia
Format Journal Article Conference Proceeding Web Resource
LanguageEnglish
Published New York, NY Elsevier Inc 15.10.2003
Elsevier Science
Pergamon-Elsevier Science Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Photodynamic therapy (PDT) is a treatment for cancer and for certain benign conditions that is based on the use of a photosensitizer and light to produce reactive oxygen species in cells. Many of the photosensitizers currently used in PDT localize in different cell compartments such as mitochondria, lysosomes, endoplasmic reticulum and generate cell death by triggering necrosis and/or apoptosis. Efficient cell death is observed when light, oxygen and the photosensitizer are not limiting (“high dose PDT”). When one of these components is limiting (“low dose PDT”), most of the cells do not immediately undergo apoptosis or necrosis but are growth arrested with several transduction pathways activated. This commentary will review the mechanism of apoptosis and growth arrest mediated by two important PDT agents, i.e. pyropheophorbide and hypericin.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
scopus-id:2-s2.0-0642345193
ISSN:0006-2952
1873-2968
1873-2968
DOI:10.1016/S0006-2952(03)00539-2